EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The NIAID/RNCP Biodosimetry Program: An Overview

Merriline M Satyamitra, David R Cassatt, Olivia Molinar-Inglis, Carmen I Rios, Lanyn P Taliaferro, Thomas A Winters, Andrea L DiCarlo

Cytogenetic and Genome Research · 2023

DOI: 10.1159/000534213 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cytogenetic and Genome Research, 2023. Verfasst von Merriline M Satyamitra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Huma…. Hauptthemen laut MEDLINE: Radioactive Hazard Release, Radiation Injuries. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Established in 2004, the Radiation and Nuclear Countermeasures Program (RNCP), within the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health has the central mission to advance medical countermeasure mitigators/therapeutics, and biomarkers and technologies to assess, triage, and inform medical management of patients experiencing acute radiation syndrome and/or the delayed effects of acute radiation exposure. The RNCP biodosimetry mission space encompasses: (1) basic research to elucidate novel approaches for rapid and accurate assessment of radiation exposure, (2) studies to support advanced development for US Food and Drug Administration (FDA) clearance of promising triage or treatment devices/approaches, (3) characterization of biomarkers and/or assays to determine degree of tissue or organ dose that can predict outcome of radiation injuries (i.e., organ failure, morbidity, and/or mortality), and (4) outreach efforts to facilitate interactions with researchers developing cutting edge biodosimetry approaches. Thus far, no biodosimetry device has been FDA cleared for use during a radiological/nuclear incident. At NIAID, advancement of radiation biomarkers and biodosimetry approaches is facilitated by a variety of funding mechanisms (grants, contracts, cooperative and interagency agreements, and Small Business Innovation Research awards), with the objective of advancing devices and assays toward clearance, as outlined in the FDA’s Radiation Biodosimetry Medical Countermeasure Devices Guidance. The ultimate goal of the RNCP biodosimetry program is to develop and establish accurate and reliable biodosimetry tools that will improve radiation preparedness and ultimately save lives during a radiological or nuclear incident.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radioactive Hazard ReleaseRadiation InjuriesUnited StatesHumansNational Institute of Allergy and Infectious Diseases (U.S.)BiomarkersRadiometry

Stichwörter der Autor:innen

Biodosimetry assaysDefinitive doseMechanismsPredictive biodosimetryResourcesTriage

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology, and Transplantation (DAIT), U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Disease…

Zitieren

APA

Satyamitra, M. M., Cassatt, D. R., Molinar-Inglis, O., Rios, C. I., Taliaferro, L. P., Winters, T. A., & DiCarlo, A. L. (2023). The NIAID/RNCP Biodosimetry Program: An Overview. Cytogenetic and Genome Research. https://doi.org/10.1159/000534213

Vancouver

Satyamitra MM, Cassatt DR, Molinar-Inglis O, Rios CI, Taliaferro LP, Winters TA, et al. The NIAID/RNCP Biodosimetry Program: An Overview. Cytogenetic and Genome Research. 2023. doi:10.1159/000534213

BibTeX
@article{Satyamitra2023,
  author = {Satyamitra, Merriline M and Cassatt, David R and Molinar-Inglis, Olivia and Rios, Carmen I and Taliaferro, Lanyn P and Winters, Thomas A and DiCarlo, Andrea L},
  title = {The NIAID/RNCP Biodosimetry Program: An Overview},
  journal = {Cytogenetic and Genome Research},
  year = {2023},
  doi = {10.1159/000534213}
}
Kostenlos starten →